USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: Genzyme Corp.
City: Boston
State: MA
Zip+4: 02111
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $261,433.00 5
SBIR Phase II $500,000.00 1

Award List:

IN RESPONSE TO THE REQUEST OF THE NATIONAL INSTITUTE OF ARTHRITIS, DIABETES AND DIGESTIVE AND KIDNEY DISEASES FOR RESEARCH INTO THE DIAGNOSIS AND TREATMENT OF "ORPHAN" INHERITED DISEASES AS OUTLINED IN THE OMNIBUS SOLICITATION FOR THE SMALL BUSINESS

Award Year / Program / Phase: 1983 / SBIR / Phase I
Agency: HHS
Principal Investigator: Henry evans blair , PRINCIPAL INVESTIGATOR
Award Amount: $61,898.00
Abstract:
In response to the request of the national institute of arthritis, diabetes and digestive and kidney diseases for research into the diagnosis and treatment of "orphan" inherited diseases as outlined in the omnibus solicitation for the small business innovative research (sbir) program: it is the aim… More

*OUR LONG TERM GOAL IS TO UTILIZE THE YEAST S.

Award Year / Program / Phase: 1984 / SBIR / Phase I
Agency: HHS
Principal Investigator: Henry evans blair , VICE PRESIDENT
Award Amount: $50,000.00
Abstract:
*our long term goal is to utilize the yeast s. cerevisiae as a vector to synthesize cloned human lysosomal enzymes with a specific oligosaccharide that will target the enzymes to tissue macrophages. this may form the basis of a novel enzyme-replacement therapy for several inherited lysosomal storage… More

HETEROANTISERA AGAINST INTERFERON (IFN) AND INTERLEUKIN-2 (IL-2) ARE HIGHLY IMMUNOSUPPRESSIVE WHEN INJECTED INTO EXPERIMENTAL ANIMALS.

Award Year / Program / Phase: 1985 / SBIR / Phase I
Agency: HHS
Principal Investigator: Donald s. masters , PRINCIPAL INVESTIGATOR
Award Amount: $49,535.00
Abstract:
Heteroantisera against interferon (ifn) and interleukin-2 (il-2) are highly immunosuppressive when injected into experimental animals. these anticytokines impair the generation of cytolytic t cells, the rejection of transplanted tumors, and other cellular immune functions. murine monoclonal… More

THE SPECIFIC AIM OF THIS PHASE I PROJECT IS TO PURIFY TO HOMOGENEITY ACIDIC A-D-MANNOSIDASE FROM HUMAN PLACENTAS AND BOVINE KIDNEYS.

Award Year / Program / Phase: 1986 / SBIR / Phase I
Agency: HHS
Principal Investigator: Shirish hirani , PRINCIPAL INVESTIGATOR
Award Amount: $50,000.00
Abstract:
The specific aim of this phase i project is to purify to homogeneity acidic a-d-mannosidase from human placentas and bovine kidneys. it is anticipated that by employing a combination of chromatographic techniques on affinity, high-performance anion exchange, and/or high performance gel filtration… More

PURIFICATION OF HIGH MANNOSE OLIGOSACCHARIDES

Award Year / Program / Phase: 1988 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $50,000.00

PURIFICATION OF HIGH MANNOSE OLIGOSACCHARIDES

Award Year / Program / Phase: 1989 / SBIR / Phase II
Agency: HHS
Principal Investigator:
Award Amount: $500,000.00
Abstract:
The long-term objectives of this proposal are to prepare pure oligosaccharides from glycoproteins possessing asparagine-linked carbohydrate chains and to use the oligosaccharides and their derivatives to investigate the structure, biosynthesis and function of the glycan chains of glycoproteins. the… More